Genexine (Korea) Odds of Future Stock Price Finishing Under 6896.7
| 095700 Stock | KRW 5,650 30.00 0.53% |
Genexine |
Genexine Target Price Odds to finish below 6896.7
The tendency of Genexine Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under W 6,897 after 90 days |
| 5,650 | 90 days | 6,897 | about 48.53 |
Based on a normal probability distribution, the odds of Genexine to stay under W 6,897 after 90 days from now is about 48.53 (This Genexine probability density function shows the probability of Genexine Stock to fall within a particular range of prices over 90 days) . Probability of Genexine price to stay between its current price of W 5,650 and W 6,897 at the end of the 90-day period is about 40.13 .
Assuming the 90 days trading horizon Genexine has a beta of 0.99. This suggests Genexine market returns are sensitive to returns on the market. As the market goes up or down, Genexine is expected to follow. Additionally Genexine has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Genexine Price Density |
| Price |
Predictive Modules for Genexine
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genexine. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Genexine Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Genexine is not an exception. The market had few large corrections towards the Genexine's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Genexine, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Genexine within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.4 | |
β | Beta against Dow Jones | 0.99 | |
σ | Overall volatility | 932.41 | |
Ir | Information ratio | -0.08 |
Genexine Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Genexine for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Genexine can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Genexine generated a negative expected return over the last 90 days | |
| Genexine has high historical volatility and very poor performance | |
| The company reported the revenue of 36.83 B. Net Loss for the year was (48.56 B) with profit before overhead, payroll, taxes, and interest of 9.76 B. | |
| Genexine has accumulated about 27.8 B in cash with (12.75 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 687.14. | |
| Roughly 21.0% of the company shares are owned by insiders or employees |
Genexine Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Genexine Stock often depends not only on the future outlook of the current and potential Genexine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genexine's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 34.5 M | |
| Cash And Short Term Investments | 27.8 B |
Genexine Technical Analysis
Genexine's future price can be derived by breaking down and analyzing its technical indicators over time. Genexine Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Genexine. In general, you should focus on analyzing Genexine Stock price patterns and their correlations with different microeconomic environments and drivers.
Genexine Predictive Forecast Models
Genexine's time-series forecasting models is one of many Genexine's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Genexine's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Genexine
Checking the ongoing alerts about Genexine for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Genexine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Genexine generated a negative expected return over the last 90 days | |
| Genexine has high historical volatility and very poor performance | |
| The company reported the revenue of 36.83 B. Net Loss for the year was (48.56 B) with profit before overhead, payroll, taxes, and interest of 9.76 B. | |
| Genexine has accumulated about 27.8 B in cash with (12.75 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 687.14. | |
| Roughly 21.0% of the company shares are owned by insiders or employees |
Other Information on Investing in Genexine Stock
Genexine financial ratios help investors to determine whether Genexine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genexine with respect to the benefits of owning Genexine security.